<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Psoriasis Cure Now! &#187; Raptiva</title>
	<atom:link href="http://www.psoriasis-cure-now.org/tag/raptiva/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.psoriasis-cure-now.org</link>
	<description>Fighting for a cure for psoriasis and psoriatic arthritis.</description>
	<lastBuildDate>Wed, 25 Jan 2012 16:04:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Raptiva (efalizumab) being pulled from US market</title>
		<link>http://www.psoriasis-cure-now.org/2009/04/08/raptiva-efalizumab-being-pulled-from-us-market/</link>
		<comments>http://www.psoriasis-cure-now.org/2009/04/08/raptiva-efalizumab-being-pulled-from-us-market/#comments</comments>
		<pubDate>Wed, 08 Apr 2009 15:52:00 +0000</pubDate>
		<dc:creator>Psoriasis Cure Now</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Immune system]]></category>
		<category><![CDATA[efalizumab]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Raptiva]]></category>

		<guid isPermaLink="false">http://psoriasis-cure-now.skybox1.com/latest-news/?p=65</guid>
		<description><![CDATA[Genentech has decided to remove Raptiva (efalizumab) from the US market.  Raptiva will become unavailable in June, 2009.
All psoriasis patients currently on Raptiva should see their physician at once and not stop taking Raptiva without consulting their physician, as significant worsening of psoriasis can occasionally occur with an abrupt withdrawal of the drug.
Raptiva was<br /><a href="http://www.psoriasis-cure-now.org/2009/04/08/raptiva-efalizumab-being-pulled-from-us-market/">READ THE FULL POST</a>]]></description>
		<wfw:commentRss></wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Important information about Raptiva (efalizumab) and PML</title>
		<link>http://www.psoriasis-cure-now.org/2009/02/24/important-information-about-raptiva-efalizumab-and-pml/</link>
		<comments>http://www.psoriasis-cure-now.org/2009/02/24/important-information-about-raptiva-efalizumab-and-pml/#comments</comments>
		<pubDate>Tue, 24 Feb 2009 02:09:00 +0000</pubDate>
		<dc:creator>Psoriasis Cure Now</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Immune system]]></category>
		<category><![CDATA[efalizumab]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[PML]]></category>
		<category><![CDATA[Raptiva]]></category>

		<guid isPermaLink="false">http://psoriasis-cure-now.skybox1.com/latest-news/?p=64</guid>
		<description><![CDATA[Raptiva is being pulled from the US market as of June 2009 due to safety issues.  **See your physician before stopping Raptiva treatment.**  More info at Raptiva.com.
]]></description>
		<wfw:commentRss></wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Raptiva gets new warning</title>
		<link>http://www.psoriasis-cure-now.org/2008/11/17/raptiva-gets-new-warning/</link>
		<comments>http://www.psoriasis-cure-now.org/2008/11/17/raptiva-gets-new-warning/#comments</comments>
		<pubDate>Mon, 17 Nov 2008 22:19:00 +0000</pubDate>
		<dc:creator>Psoriasis Cure Now</dc:creator>
				<category><![CDATA[Biologics]]></category>
		<category><![CDATA[Immune system]]></category>
		<category><![CDATA[efalizumab]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[PML]]></category>
		<category><![CDATA[Raptiva]]></category>

		<guid isPermaLink="false">http://psoriasis-cure-now.skybox1.com/latest-news/?p=82</guid>
		<description><![CDATA[From a Genentech news release:
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva (efalizumab) for approximately four years for treatment of<br /><a href="http://www.psoriasis-cure-now.org/2008/11/17/raptiva-gets-new-warning/">READ THE FULL POST</a>]]></description>
		<wfw:commentRss></wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

